NCT04800211View on ClinicalTrials.gov

Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products

NACompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

July 20, 2018

Study Completion Date

November 6, 2018

Conditions
Tobacco Use
Interventions
OTHER

Experimental: Test Product 1

Subjects were instructed to completely replace their cigarettes with the Test Product 1 EVP (Nu Mark LLC, MarkTen® XL Bold CLASSIC)

OTHER

Experimental: Test Product 2

Subjects were instructed to completely replace their cigarettes with the Test Product 2 EVP (Nu Mark LLC, MarkTen® XL Bold MENTHOL)

Trial Locations (10)

27265

High Point Clinical Trials Center, High Point

27617

Rose Research Center, LLC, Raleigh

37920

New Orleans Center for Clinical Research, Knoxville

40509

Central Kentucky Research Associates, Lexington

55404

DaVita Clinical Research, Minneapolis

65802

QPS Bio-Kinetic, Springfield

67207

Heartland Research Associates, LLC, Wichita

68502

Celerion, Lincoln

89119

Clinical Research Consortium, Las Vegas

91505

LA Clinical Trials, Burbank

All Listed Sponsors
lead

Altria Client Services LLC

INDUSTRY

NCT04800211 - Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products | Biotech Hunter | Biotech Hunter